Compare D Wave Quantum Inc (QBTS) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
D Wave Quantum Inc vs Tenet Healthcare Corporation — how do they compare? D Wave Quantum Inc trades at $14.9 (market cap $5.78B), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: Tenet Healthcare Corporation is far larger — about 3.6× D Wave Quantum Inc's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, D Wave Quantum Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold D Wave Quantum Inc for 32 Days and Tenet Healthcare Corporation for 15 Days on average.
| QBTS | THC | |
|---|---|---|
Market Cap | $5.78B | $20.92B |
Volume | 14,335,003 | 455,764 |
Sector | Technology | Health |
52-Week High | $44.78 | $280.77 |
52-Week Low | $12.98 | $161.37 |
Typical Hold Time | 32 Days | 15 Days |
Enterprise Value | $5.28B | $32.00B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
QBTS (D-Wave Quantum Inc.) trades at $15.22, down 3.61% on the day, amid a bearish technical signal despite a 100% analyst buy rating with a consensus price target of $34.38. The company shows significant financial strain with a net income margin of -2,001.59% and negative cash flow from operations, though it maintains a high gross margin of 64.19%. Recent news highlights ongoing fraud investigations alongside technological advancements in quantum computing.
The stock presents high risk due to severe losses and cash burn, but offers speculative upside if the company can monetize its quantum technology. Investors face substantial volatility from operational challenges and legal scrutiny, requiring caution despite Wall Street optimism.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About D Wave Quantum Inc
D-Wave Quantum Inc. is a global leader in the development and delivery of quantum computing systems, software, and services. The company specializes in annealing quantum computers designed to solve complex optimization problems across industries such as logistics, materials science, and financial modeling. D-Wave offers its technology through the cloud, allowing customers to build and run real-world quantum applications today, making it a key player in the commercialization of quantum computing.
Read more on QBTS →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
